These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2719340

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
    Krupiński K, Bielawiec M, Szpak A, Płonowski A.
    Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
    [Abstract] [Full Text] [Related]

  • 43. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 44. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 45. Variability and reproducibility of transcutaneous oxygen tension measurements in the assessment of peripheral vascular disease.
    Rooke TW, Osmundson PJ.
    Angiology; 1989 Aug 30; 40(8):695-700. PubMed ID: 2757262
    [Abstract] [Full Text] [Related]

  • 46. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Aug 30; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 47. Prevalence and Causes of Normal Exercise Oximetry in the Calf in Patients with Peripheral Artery Disease and Limiting Calf Claudication.
    Signolet I, Henni S, Colas-Ribas C, Feuilloy M, Picquet J, Abraham P.
    Eur J Vasc Endovasc Surg; 2016 Apr 30; 51(4):572-8. PubMed ID: 26905471
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Tissue pO2 and transcutaneous pO2 as guidelines in experimental and clinical drug evaluation.
    Sunder-Plassmann L, Messmer K, Becker HM.
    Angiology; 1981 Oct 30; 32(10):686-98. PubMed ID: 7325405
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Vasoactive effects of buflomedil assessed by fluorescein angiography.
    Platania A, Sciuto V, De Martino Rosaroll G.
    Curr Med Res Opin; 1987 Oct 30; 10(7):457-67. PubMed ID: 3621991
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Value of measuring transcutaneous oxygen pressure in arterial disease of the legs].
    Becker F, Gabrielle F, Raoux MH, Brenot R, David M.
    Ann Cardiol Angeiol (Paris); 1989 Oct 30; 38(8):465-72. PubMed ID: 2596817
    [Abstract] [Full Text] [Related]

  • 54. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May 30; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Metabolic effects of buflomedil hydrochloride.
    Briguglio F, Di Marco V, Circosta C, Padovano I, Ragusa S, Saija A, Briguglio E.
    J Int Med Res; 1985 May 30; 13(3):131-58. PubMed ID: 2989026
    [No Abstract] [Full Text] [Related]

  • 58. [Value of transcutaneous staged dynamic oximetry of stage II arteritis of the leg].
    Grard C, Desmytterre J, Vinckier L, Hatron PY, Roux JP, Warembourg H, Devulder B.
    Arch Mal Coeur Vaiss; 1990 Mar 30; 83 Spec No 2():51-7. PubMed ID: 2111687
    [Abstract] [Full Text] [Related]

  • 59. [Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs].
    Allegra C, Andreozzi GM, Avellone G, Cospite M, Del Guercio R, Lepore R, Nuzzaci G, Pinto A, Romeo S.
    Clin Ter; 1986 Oct 15; 119(1):25-33. PubMed ID: 3539466
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.